Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Afeyan"


4 mentions found


If you need to tackle an improbable challenge, the right mindset — "a special kind of optimism" — can help, according to Moderna co-founder and chairman Noubar Afeyan. Specifically, Afeyan — who has an estimated net worth of $1.5 billion, according to Forbes — said that "extraordinary change agents" take three actions to achieve what seems impossible:They imagine. Imagination plays a crucial role "in accomplishing impossible missions," Afeyan said: You typically need to think creatively to come up with new, original ideas. But ask yourself one central question: Why do we expect extraordinary results from reasonable people doing reasonable things?" "You need to leave your comfort zone, to think in new ways, to acclimate to the unfamiliar and embrace uncertainty."
Persons: Noubar Afeyan, he's, Afeyan —, Forbes —, Afeyan, Allison Butler, Butler Organizations: Moderna, Massachusetts Institute of Technology, MIT, Sloan School of Management, Bryant University, CNBC Locations: Lebanon, Canada, Massachusetts, Cambodia, California, Cambridge, acclimate
Moderna — The pharmaceutical company lost more than 8% Monday, making it the biggest decliner in the S&P 500. Enphase Energy — Shares lost 2.6% after Citi lowered its price target on shares to $170 from $209 while keeping its buy rating. The new price target implies 41% upside from Friday's close. Analyst Chris Quintero highlighted the growth opportunity for the company following a strong investment cycle. The investment bank bumped up the stock's price target to $40 from $37, citing Simply Good Foods' diverse product offering and shifting consumer preferences to healthier choices as catalysts.
Persons: Bernstein, Needham, Noubar Afeyan, Moderna's, Goldman Sachs, Mark Delaney, PayP, Ralph Lauren —, Ralph Lauren's, TD Cowen, Cowen, Tenable, Morgan Stanley, Chris Quintero, Raymond James, ASGN, Wells Fargo, , Alex Harring, Brian Evans, Samantha Subin, Yun Li, Lisa Kailai Han, Pia Singh, Michelle Fox Organizations: — Petroleum refiners Valero Energy, Marathon Petroleum, West Texas Intermediate, Brent, Energy, Arm, Nasdaq, Securities and Exchange Commission, Pharmaceutical, Pfizer, U.S, Tesla, PayPal, MoffetNathanson, Guggenheim, Enphase Energy, Citi, Tenable Holdings, Mizuho, Aldi, Lowe's, Micron Technology, Deutsche Bank, Paramount, Disney, Warner Bros Discovery, Iridium Communications, Iridium Locations: Valero Houston, Houston , Texas, U.S
Afeyan is the CEO and founder of Flagship Pioneering, the venture firm behind Moderna. Flagship has in its portfolio multiple companies using AI in areas like drug discovery and testing. The Flagship method for company building starts with a vague "what if" question, and if the idea survives testing, it's unveiled to the public, Afeyan told Insider in 2021. Afeyan isn't alone in predicting that generative AI is gearing up to play a bigger role in healthcare. Morgan Cheatham, a vice president at Bessemer Venture Partners, told Insider he predicted generative AI would result in more than $1 trillion in value for the healthcare industry by 2040.
Insider found 16 pioneers in the world of biotech venture capital who are shaping the industry. But new investors are joining the ranks of biotech venture capitalists every day, and they're bringing new ideas with them. Insider set out to identify the rising stars writing biotech's next chapter and ended up with a wide-ranging group of 16 investors shaping the industry. According to these people, the 16 names on this list represent some of the brightest minds in the VC world and are using their intellect to shake things up. Here are the 16 rising stars of biotech investing, according to investors, academics, and entrepreneurs.
Total: 4